Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis

Oncology Reports

Volumn 16, Issue 4, 2006, Pages 705-711

  Takikawa, Masako ^a   Akiyama, Yasuto ^a   Maruyama, Kouji ^a   Suzuki, Ayako ^a   Liu, Feng ^a   Tai, Sachiko ^a   Ohshita, Chie ^a   Kawaguchi, Yoshihiro ^a   Bandou, Etsurou ^a   Yonemura, Yutaka ^a   Yamaguchi, Ken ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Gastric cancer; Matrix assisted laser desorption ionization time of flight mass spectrometry; Peritoneal dissemination; Two dimensional differential gel electrophoresis

Indexed keywords

FLUORESCENT DYE; PROTEOME;

ARTICLE; GENE EXPRESSION REGULATION; HUMAN; MASS SPECTROMETRY; METABOLISM; METASTASIS; METHODOLOGY; PATHOLOGY; PROTEOMICS; STOMACH TUMOR; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MASS SPECTROMETRY; NEOPLASM METASTASIS; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS;

EID: 34547800061     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.4.705     Document Type: Article

References (27)

1. Yonemura Y, Endo Y, Yamaguchi T, et al: Mechanism of the formation of the peritoneal dissemination in gastric cancer. Int J Oncol 8: 795-802, 1996. (Pubitemid 26109946)
2. Yawata A, Adachi M, Okuda H, et al: Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene 16: 2681-2686, 1998. (Pubitemid 28264045)
3. Tahara E: Molecular aspects of invasion and metastasis of stomach cancer. Verh Dtsch Ges Pathol 84: 43-49, 2000.
4. Yonemura Y, Endo Y, Nojima N, et al: A possible role of cytokines in the formation of peritoneal dissemination. Int J Oncol 11: 349-358, 1997. (Pubitemid 27305968)
5. Hippo Y, Yashiro M, Ishii M, et al: Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61: 889-895, 2001. (Pubitemid 32174397)
6. Sakakura C, Hagiwara A, Nakanishi M, et al: Differential gene expression profiles of gastric cancer cells established from primary tumor and malignant ascites. Br J Cancer 87: 1153-1161, 2002. (Pubitemid 35422719)
7. Gharbi S, Gaffney P, Yang A, et al: Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 1: 91-98, 2002.
8. Alfonso P, Nunez A, Madoz-Gurpide J, Lombardia L, Sanchez L and Casal JI: Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 5: 2602-2611, 2005. (Pubitemid 40966487)
9. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW, et al: The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14: 491-499, 2004. (Pubitemid 39551562)
10. Ryu JW, Kim HJ, Lee YS, et al: The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 18: 505-509, 2003.
11. Takano Y, Kato Y, van Diest PJ, Masuda M, Mitomi H and Okayasu I: Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 156: 585-594, 2000. (Pubitemid 30643814)
12. Seo YH, Joo YE, Choi SK, Rew JS, Park CS and Kim SJ: Prognostic significance of p21 and p53 expression in gastric cancer. Korean J Intern Med 18: 98-103, 2003.
13. Seegert D, Strehlow I, Klose B, Levy DE, Schindler C and Decker T: A novel interferon-alpha-regulated, DNA-binding protein participates in the regulation of the IFP53/tryptophanylt-RNA synthetase gene. J Biol Chem 269: 8590-8595, 1994.
14. Kim SW, Hayashi M, Lo JF, et al: Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8. Cancer Res 65: 8784-8791, 2005. (Pubitemid 41377366)
15. Ren Y, Poon RT, Tsui HT, et al: Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 9: 5996-6001, 2003. (Pubitemid 38018086)
16. Konno H, Ohta M, Baba M, Suzuki S and Nakamura S: The role of circulating IL-8 and VEGF protein in the progression of gastric cancer. Cancer Sci 94: 735-740, 2003. (Pubitemid 37160933)
17. Tzima E and Schimmel P: Inhibition of tumor angiogenesis by a natural fragment of a tRNA synthetase. Trends Biochem Sci 31: 7-10, 2005.
18. Ewalt KL and Schimmel P: Activation of angiogenic signaling pathways by two human tRNA synthetases. Biochemistry 41: 13344-13349, 2002. (Pubitemid 35303892)
19. Aslanian AM, Fletcher BS and Kilberg MS: Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem J 357: 321-328, 2001. (Pubitemid 32642933)
20. Kubota K, Nakanishi H, Hiki N, et al: Quantitative detection of micrometastasis in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. Int J Cancer 105: 136-143, 2003. (Pubitemid 36418499)
21. Ugurel S, Bell N, Sucker A, Zimpfer A, Rittgen W and Schadendorf D: Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma. Int J Cancer 117: 825-830, 2005. (Pubitemid 41598835)
22. Yoo BC, Ku JL, Hong SH, et al: Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines. Int J Cancer 108: 532-539, 2004. (Pubitemid 38036653)
23. Emoto K, Sawada H, Yamada Y, et al: Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21: 1339-1345, 2001.
24. Garcia-Pedrero JM, Fernandez MP, Morgan RO, et al: Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164: 73-79, 2004. (Pubitemid 38364592)
25. Chiang WL, Chu SC, Yang SS, et al: The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. Cancer Lett 188: 199-205, 2002.
26. Bekku S, Mochizuki H, Yamamoto T, Ueno H, Takayama E and Tadakuma T: Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology 47: 998-1001, 2000.
27. Malloory JC, Crudden G, Oliva A, Saunders C, Stromberg A and Craven RJ: A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells. Mol Pharmacol 68: 1747-1756, 2005. (Pubitemid 41656027)